Cytotoxicity reduction by O-nicotinoylation of antiviral 6-benzylaminopurine ribonucleosides. (August 2022)
- Record Type:
- Journal Article
- Title:
- Cytotoxicity reduction by O-nicotinoylation of antiviral 6-benzylaminopurine ribonucleosides. (August 2022)
- Main Title:
- Cytotoxicity reduction by O-nicotinoylation of antiviral 6-benzylaminopurine ribonucleosides
- Authors:
- Zenchenko, Anastasia A.
Oslovsky, Vladimir E.
Varizhuk, Irina V.
Karpova, Evgenia V.
Osolodkin, Dmitry I.
Kozlovskaya, Liubov I.
Ishmukhametov, Aydar A.
Drenichev, Mikhail S. - Abstract:
- Abstract: One of the promising approaches in the development of nucleoside prodrugs is to use the nucleoside analogs containing lipophilic biodegradable residues, which are cleaved to biologically active forms after metabolic transformations in the cell. The introduction of such fragments makes it possible to reduce the general toxicity of the drug candidate and increase its stability in the cell. In order to study the influence of biodegradable lipophilic groups on antiviral activity and cytotoxicity, in this work we synthesized N 6 -benzyl-2′, 3′, 5′-tri- O -nicotinoyl adenosine and N 6 -(3-fluorobenzyl)-2′, 3′, 5′-tri- O -nicotinoyl adenosine, derivatives of N 6 -benzyladenosine (BAR) and N 6 -(3-fluorobenzyl)adenosine (FBAR), which had previously shown prominent antiviral activity against human enterovirus EV-A71 but appeared to be cytotoxic. The obtained fully- O -nicotinoylated BAR and FBAR inhibited reproduction of EV-A71 strains BrCr and 46973 and manifested significantly lower cytotoxicity compared to non-protected compounds. In addition, we performed enzymatic hydrolysis of the fully- O -nicotinoylated FBAR in the presence of esterases (CalB and PLE) to investigate metabolic degradation of O -nicotinoylated compounds in cells. Both enzymes hydrolyzed the tested substrate to form the corresponding O -deprotected nucleoside that may suggest the role of hydrolase-type enzymes as general participants of metabolic activation of O -nicotinoylated prodrugs in differentAbstract: One of the promising approaches in the development of nucleoside prodrugs is to use the nucleoside analogs containing lipophilic biodegradable residues, which are cleaved to biologically active forms after metabolic transformations in the cell. The introduction of such fragments makes it possible to reduce the general toxicity of the drug candidate and increase its stability in the cell. In order to study the influence of biodegradable lipophilic groups on antiviral activity and cytotoxicity, in this work we synthesized N 6 -benzyl-2′, 3′, 5′-tri- O -nicotinoyl adenosine and N 6 -(3-fluorobenzyl)-2′, 3′, 5′-tri- O -nicotinoyl adenosine, derivatives of N 6 -benzyladenosine (BAR) and N 6 -(3-fluorobenzyl)adenosine (FBAR), which had previously shown prominent antiviral activity against human enterovirus EV-A71 but appeared to be cytotoxic. The obtained fully- O -nicotinoylated BAR and FBAR inhibited reproduction of EV-A71 strains BrCr and 46973 and manifested significantly lower cytotoxicity compared to non-protected compounds. In addition, we performed enzymatic hydrolysis of the fully- O -nicotinoylated FBAR in the presence of esterases (CalB and PLE) to investigate metabolic degradation of O -nicotinoylated compounds in cells. Both enzymes hydrolyzed the tested substrate to form the corresponding O -deprotected nucleoside that may suggest the role of hydrolase-type enzymes as general participants of metabolic activation of O -nicotinoylated prodrugs in different cells. Graphical abstract: Unlabelled Image Highlights: 6-Benzylaminopurine ribonucleosides with biodegradable O- nicotinoyl ester moieties. Fully- O -nicotinoylated nucleosides exhibit decrease in cytotoxicity in RD cells. Fully- O -nicotinoylated nucleosides manifest antiviral activity against EV-A71. Gradual hydrolysis of fully- O -nicotinoylated nucleosides in the presence of esterases. … (more)
- Is Part Of:
- Toxicology in vitro. Volume 82(2022)
- Journal:
- Toxicology in vitro
- Issue:
- Volume 82(2022)
- Issue Display:
- Volume 82, Issue 2022 (2022)
- Year:
- 2022
- Volume:
- 82
- Issue:
- 2022
- Issue Sort Value:
- 2022-0082-2022-0000
- Page Start:
- Page End:
- Publication Date:
- 2022-08
- Subjects:
- 6-Benzylaminopurine ribonucleosides -- O-Nicotinoylation -- Biodegradable lipophilic groups -- Cytotoxicity reduction -- Antiviral activity -- Enterovirus EV-A71
Toxicity testing -- In vitro -- Periodicals
Toxicology -- Periodicals
615.9 - Journal URLs:
- http://www.sciencedirect.com/science/journal/08872333 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.tiv.2022.105355 ↗
- Languages:
- English
- ISSNs:
- 0887-2333
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 8873.043400
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 21564.xml